All

MDoloris Medical Systems & Mindray announce the CE Mark and launch of their Analgesia Nociception Index MR module in Europe.
15 December 2021

MDoloris Medical Systems & Mindray announce the CE Mark and launch of their Analgesia Nociception Index MR module in Europe.

MDoloris Medical Systems, leader in the field of objective analgesia/nociception monitoring during anesthesia and in intensive care, and Mindray, a global leader in developing...

Read the press release
MDoloris Medical Systems announces the regulatory clearance and the upcoming launch of its Analgesia Nociception Index platform in Japan with Heiwa Bussan
17 November 2021

MDoloris Medical Systems announces the regulatory clearance and the upcoming launch of its Analgesia Nociception Index platform in Japan with Heiwa Bussan

MDoloris Medical Systems, a leader in the field of objective pain monitoring during anesthesia, announces today the regulatory clearance and marketing approval of its HFVI...

Read the press release
MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris
3 November 2021

MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris

MaaT Pharma S.A. ("MaaT Pharma" or the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome2-based ecosystem therapies dedicated to...

Read the press release
Axial Therapeutics Receives FDA Clearance of IND Application and Initiates Phase 2b Trial for AB-2004, Lead Gut-Targeted, Molecular Therapeutic for the Treatment of Irritability in Autism Spectrum Disorder
27 October 2021

Axial Therapeutics Receives FDA Clearance of IND Application and Initiates Phase 2b Trial for AB-2004, Lead Gut-Targeted, Molecular Therapeutic for the Treatment of Irritability in Autism Spectrum Disorder

Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological disorders and diseases, today announced that the...

Read the press release
CattleEye Announce $2.5m Seed Investment
14 October 2021

CattleEye Announce $2.5m Seed Investment

Belfast-based livestock monitoring technology company CattleEye announced today that it has closed a $2.5m seed investment round from a syndicate led by Techstart Ventures and...

Read more
Digital Aquaculture Innovator Ecto Raises $7M in Series A Round from Rabobank and Aqua-Spark
14 October 2021

Digital Aquaculture Innovator Ecto Raises $7M in Series A Round from Rabobank and Aqua-Spark

Aquaculture data analytics disrupter Ecto has raised $7 million in financing led by the Rabo Food & Agri Innovation Fund and Aqua-Spark. New investor Seventure Partners also...

Read more
BiomX Announces Agreement with Maruho Co., Ltd. for Atopic Dermatitis Product Candidate BX005
13 October 2021

BiomX Announces Agreement with Maruho Co., Ltd. for Atopic Dermatitis Product Candidate BX005

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage cocktails that target...

Read the press release
CAPZA acquires a majority stake in Web Geo Services
30 June 2021

CAPZA acquires a majority stake in Web Geo Services

CAPZA Growth Tech invests in Web Geo Services to make it a leading international player in Geolocation Intelligence.

Read more
Axial Therapeutics Raises $37.25 Million in Series C Financing to Advance its Pipeline of Gut-Targeted Small Molecule Drugs for Neurological Diseases and Disorders
13 October 2021

Axial Therapeutics Raises $37.25 Million in Series C Financing to Advance its Pipeline of Gut-Targeted Small Molecule Drugs for Neurological Diseases and Disorders

Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases, today announced the completion of a $37.25...

Read more